SL
NVO

Savior LLC’s Novo Nordisk NVO Stock Holding History

Savior LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34
Closed -$1K – 573
2021
Q2 		$1K Hold
34
– – ﹤0.01% 812
2021
Q1 		$1K Hold
34
– – ﹤0.01% 832
2020
Q4 		$1K Hold
34
– – ﹤0.01% 804
2020
Q3 		$1K Hold
34
– – ﹤0.01% 778
2020
Q2 		$1K Sell
34
-86
-72% -$2.74K ﹤0.01% 755
2020
Q1 		$4K Hold
120
– – ﹤0.01% 502
2019
Q4 		$3K Buy
+120
New +$3.32K ﹤0.01% 697

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Savior LLC's NVO Position: Q3 2021 in Review

Savior LLC sold out of Novo Nordisk (NVO) in Q3 2021, closing a stake of 34 shares — an estimated $1K sold.

Savior LLC first reported a position in NVO in Q4 2019 and held it in 7 quarters. The position peaked at $4K in Q1 2020. 804 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • Savior LLC reported no remaining Novo Nordisk position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 34 Novo Nordisk shares in Q3 2021, an estimated $1K.
  • Savior LLC first reported a position in Novo Nordisk in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Novo Nordisk position peaked at $4K in Q1 2020.
  • 804 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.